Abstract
Prior studies have indicated that the β4 integrin promotes mammary tumor invasion and metastasis by combining with ErbB2 and amplifying its signaling capacity. However, the effector pathways and cellular functions by which the β4 integrin exerts these effects are incompletely understood. To examine if β4 signaling plays a role during mammary tumor cell adhesion to microvascular endothelium, we have examined ErbB2-transformed mammary tumor cells expressing either a wild-type (WT) or a signaling-defective form of β4 (1355T). We report that WT cells adhere to brain microvascular endothelium in vitro to a significantly larger extent as compared to 1355T cells. Interestingly, integrin β4 signaling does not exert a direct effect on adhesion to the endothelium or the underlying basement membrane. Rather, it enhances ErbB2-dependent expression of VEGF by tumor cells. VEGF in turn disrupts the tight and adherens junctions of endothelial monolayers, enabling the exposure of underlying basement membrane and increasing the adhesion of tumor cells to the intercellular junctions of endothelium. Inhibition of ErbB2 on tumor cells or the VEGFR-2 on endothelial cells suppresses mammary tumor cell adhesion to microvascular endothelium. Our results indicate that β4 signaling regulates VEGF expression by the mammary tumor cells thereby enhancing their adhesion to microvascular endothelium.
Similar content being viewed by others
References
Abdel-Ghany, M., H. C. Cheng, R. C. Elble, and B. U. Pauli. Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth. J. Biol. Chem. 277:34391–34400, 2002.
Adamson, R. H., J. F. Lenz, X. Zhang, G. N. Adamson, S. Weinbaum, and F. E. Curry. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J. Physiol. 557:889–907, 2004.
Astolfi, A., L. Landuzzi, G. Nicoletti, C. De Giovanni, S. Croci, A. Palladini, S. Ferrini, M. Iezzi, P. Musiani, F. Cavallo, G. Forni, P. Nanni, and P. L. Lollini. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. Am. J. Pathol. 166:1205–1216, 2005.
Brown, R. C., A. P. Morris, and R. G. O’Neil. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res. 1130:17–30, 2007.
Burns, A. R., R. A. Bowden, Y. Abe, D. C. Walker, S. I. Simon, M. L. Entman, and C. W. Smith. P-selectin mediates neutrophil adhesion to endothelial cell borders. J. Leukoc. Biol. 65:299–306, 1999.
Burns, A. R., D. C. Walker, E. S. Brown, L. T. Thurmon, R. A. Bowden, C. R. Keese, S. I. Simon, M. L. Entman, and C. W. Smith. Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. J. Immunol. 159:2893–2903, 1997.
Chambers, A. F., A. C. Groom, and I. C. MacDonald. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2:563–572, 2002.
Chung, J., R. E. Bachelder, E. A. Lipscomb, L. M. Shaw, and A. M. Mercurio. Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J. Cell Biol. 158:165–174, 2002.
Dans, M., L. Gagnoux-Palacios, P. Blaikie, S. Klein, A. Mariotti, and F. G. Giancotti. Tyrosine phosphorylation of the beta 4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes. J. Biol. Chem. 276:1494–1502, 2001.
Fischer, S., M. Wobben, H. H. Marti, D. Renz, and W. Schaper. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc. Res. 63:70–80, 2002.
Fu, B. M., and S. Shen. Acute VEGF effect on solute permeability of mammalian microvessels in vivo. Microvasc. Res. 68:51–62, 2004.
Gavard, J., and J. S. Gutkind. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8:1223–1234, 2006.
Giancotti, F. G. Targeting integrin beta4 for cancer and anti-angiogenic therapy. Trends Pharmacol. Sci. 28:506–511, 2007.
Giancotti, F. G., and E. Ruoslahti. Integrin signaling. Science 285:1028–1032, 1999.
Guo, W., and F. G. Giancotti. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5:816–826, 2004.
Guo, W., Y. Pylayeva, A. Pepe, T. Yoshioka, W. J. Muller, G. Inghirami, and F. G. Giancotti. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126:489–502, 2006.
He, P., J. Wang, and M. Zeng. Leukocyte adhesion and microvessel permeability. Am. J. Physiol. Heart Circ. Physiol. 278:H1686–H1694, 2000.
Hood, J. D., and D. A. Cheresh. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2:91–100, 2002.
Khanna, P., T. Yunkunis, H. S. Muddana, H. H. Peng, A. August, and C. Dong. p38 MAP kinase is necessary for melanoma-mediated regulation of VE-cadherin disassembly. Am. J. Physiol. Cell Physiol. 298:C1140–C1150, 2010.
Kienast, Y., L. von Baumgarten, M. Fuhrmann, W. E. Klinkert, R. Goldbrunner, J. Herms, and F. Winkler. Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 16:116–122, 2010.
Lee, T. H., H. K. Avraham, S. Jiang, and S. Avraham. Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. J. Biol. Chem. 278:5277–5284, 2003.
Li, G., M. J. Simon, L. M. Cancel, Z. D. Shi, X. Ji, J. M. Tarbell, B. Morrison, III, and B. M. Fu. Permeability of endothelial and astrocyte cocultures: in vitro blood–brain barrier models for drug delivery studies. Ann. Biomed. Eng. 38:2499–2511, 2010.
Litjens, S. H., J. M. de Pereda, and A. Sonnenberg. Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol. 16:376–383, 2006.
Martin-Padura, I., S. Lostaglio, M. Schneemann, L. Williams, M. Romano, P. Fruscella, C. Panzeri, A. Stoppacciaro, L. Ruco, A. Villa, D. Simmons, and E. Dejana. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142:117–127, 1998.
Moasser, M. M., A. Basso, S. D. Averbuch, and N. Rosen. The tyrosine kinase inhibitor ZD1839 (“Iressa”) inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res. 61:7184–7188, 2001.
Muller, W. J., E. Sinn, P. K. Pattengale, R. Wallace, and P. Leder. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105–115, 1988.
Nikolopoulos, S. N., P. Blaikie, T. Yoshioka, W. Guo, and F. G. Giancotti. Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 6:471–483, 2004.
Norton, L., and J. Massague. Is cancer a disease of self-seeding? Nat. Med. 12:875–878, 2006.
Ostermann, G., K. S. Weber, A. Zernecke, A. Schröder, and C. Weber. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3:151–158, 2002.
Palmieri, D., Q. R. Smith, P. R. Lockman, J. Bronder, B. Gril, A. F. Chambers, R. J. Weil, and P. S. Steeg. Brain metastases of breast cancer. Breast Dis. 26:139–147, 2006.
Santoso, S., V. V. Orlova, K. Song, U. J. Sachs, C. L. Andrei-Selmer, and T. Chavakis. The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J. Biol. Chem. 280:36326–36333, 2005.
Senger, D. R., C. A. Perruzzi, J. Feder, and H. F. Dvorak. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46:5629–5632, 1986.
Serini, G., L. Trusolino, E. Saggiorato, O. Cremona, M. De Rossi, A. Angeli, F. Orlandi, and P. C. Marchisio. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J. Natl. Cancer Inst. 88:442–449, 1996.
Shen, S., J. Fan, B. Cai, Y. Lv, M. Zeng, Y. Hao, F. G. Giancotti, and B. M. Fu. Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo. Exp. Physiol. 95:369–379, 2010.
Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182, 1987.
Spinardi, L., S. Einheber, T. Cullen, T. A. Milner, and F. G. Giancotti. A recombinant tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress alpha 6 beta 4-mediated cell adhesion to laminins. J. Cell Biol. 129:473–487, 1995.
Spinardi, L., Y. L. Ren, R. Sanders, and F. G. Giancotti. The beta 4 subunit cytoplasmic domain mediates the interaction of alpha 6 beta 4 integrin with the cytoskeleton of hemidesmosomes. Mol. Biol. Cell 4:871–884, 1993.
Steeg, P. S., and D. Theodorescu. Metastasis: a therapeutic target for cancer. Nat. Clin. Pract. Oncol. 5:206–219, 2008.
Trusolino, L., A. Bertotti, and P. M. Comoglio. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107:643–654, 2001.
Wang, W., W. L. Dentler, and R. T. Borchardt. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am. J. Physiol. Heart Circ. Physiol. 280:H434–H440, 2001.
Weis, S., J. Cui, L. Barnes, and D. Cheresh. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J. Cell Biol. 167:223–229, 2004.
Xia, Y., S. G. Gil, and W. G. Carter. Anchorage mediated by integrin alpha6beta4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein. J. Cell Biol. 132:727–740, 1996.
Yuan, W., G. Li, E. S. Gil, T. L. Lowe, and B. M. Fu. Effect of surface charge of immortalized mouse cerebral endothelial cell monolayer on transport of charged solutes. Ann. Biomed. Eng. 38:1463–1472, 2010.
Acknowledgment
This work was supported by NIH grants P20 CA118861, U54 CA137788, SC1 CA153325, R37 CA058976, R01 CA129023, as well as P30 CA08748. Mr. Jie Fan was partially supported by a scholarship from the China Scholarship Council. We thank Dr. Robert Majeska for his kind helps in language editing.
Conflict of interest
This is no conflict of interests with any corporations and agencies.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Cheng Dong oversaw the review of this article.
Filippo G. Giancotti and Bingmei M. Fu have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Fan, J., Cai, B., Zeng, M. et al. Integrin β4 Signaling Promotes Mammary Tumor Cell Adhesion to Brain Microvascular Endothelium by Inducing ErbB2-Mediated Secretion of VEGF. Ann Biomed Eng 39, 2223–2241 (2011). https://doi.org/10.1007/s10439-011-0321-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-011-0321-6